ÂÜÀòÂÒÂ×

Sean O'Flynn serves as the National Sales Director at Daxor Corporation since July 2020, focusing on the innovative BVA-100, a pioneering FDA-cleared blood volume diagnostic tool. O'Flynn's extensive experience includes consulting for biomedical clients and previous roles such as District Sales Manager at Ironshore Pharmaceuticals and Vice President of Business Development at Renu Contracting and Restoration. O'Flynn has successfully built sales teams and strategies at prominent health service and medical technology companies like BrightSpring Health Services and Medtronic Diabetes, demonstrating a strong track record in driving sales performance and market expansion. Early career achievements include leading teams at Medtronic and GlaxoSmithKline to top district performance and award recognition. Sean O'Flynn graduated with a BA in History/Political Science from Colgate University and previously attended the University of New Haven.